VNDA
Vanda Pharmaceuticals Inc
Price:  
5.92 
USD
Volume:  
878,486.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VNDA WACC - Weighted Average Cost of Capital

The WACC of Vanda Pharmaceuticals Inc (VNDA) is 5.9%.

The Cost of Equity of Vanda Pharmaceuticals Inc (VNDA) is 8.05%.
The Cost of Debt of Vanda Pharmaceuticals Inc (VNDA) is 5.00%.

Range Selected
Cost of equity 6.10% - 10.00% 8.05%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.9% - 6.8% 5.9%
WACC

VNDA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.48 0.92
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 10.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.9% 6.8%
Selected WACC 5.9%